Clinical Trial Update: TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma [NA]

View source ↗

Summary

A completed clinical trial evaluating transarterial chemoembolization with immune agents to target angiogenesis in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: The First Hospital of Hebei Medical University | Conditions: Hepatocellular Carcinoma (HCC) | NA | Status: COMPLETED